DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy
Hims prescribes oral finasteride and topical minoxidil — the two FDA-cleared treatments with the strongest evidence for male pattern hair loss.
A convenient, evidence-backed combo with real caveats
Hims Hair bundles the two best-studied male-pattern-baldness ingredients into one prescription spray, delivered through a telehealth visit for around $35/month. The individual drugs work, and combining a DHT-blocker with a follicle-stimulator is a sound, well-supported strategy. The honest catch: this specific topical, compounded formulation is not FDA-approved as a finished product, and in April 2025 the FDA issued a safety alert about sexual and neuropsychiatric side effects reported with compounded topical finasteride, some of which persisted after stopping.
We may earn a commission if you buy through this link, at no extra cost to you. It never affects our score. How we make money
Independent third-party ratings, shown for context. Not affiliated with HealthVetted scoring.
Hims doesn't invent hair-loss science — it packages it. The active ingredients in every Hims hair product are finasteride and minoxidil, both decades old and both well studied. So a fair review splits into two questions: *Do these drugs work?* (yes, with real numbers) and *Is buying them through Hims a good deal and a safe one?* (it depends on which product and which competitor you compare against). Below we treat both honestly.
Hims (Hims & Hers Health, NYSE: HIMS) is a US telehealth company that sells prescription and over-the-counter treatments for hair loss, erectile dysfunction, mental health, and weight management. For hair, it offers minoxidil (the only over-the-counter item), oral finasteride, and combination topical sprays that mix finasteride and minoxidil.
The flow is almost entirely asynchronous. You complete an online intake form covering symptoms, photos, and medical history; a provider licensed in your state reviews it, and — if appropriate — issues a prescription that a partner pharmacy fills and ships discreetly. There is usually no live video visit. The consultation is free, and you only pay if a prescription is written and you accept the subscription (Hims).
Two practical points that shape the rest of this review:
The two drugs attack male-pattern hair loss (androgenetic alopecia) by completely different mechanisms, which is why they're commonly used together.
Finasteride is a 5-alpha-reductase type II inhibitor. It blocks the enzyme that converts testosterone into dihydrotestosterone (DHT), the androgen that miniaturizes genetically susceptible scalp follicles. Oral finasteride 1 mg lowers scalp and serum DHT substantially, halting the hormonal driver of balding (FDA PROPECIA label, accessdata.fda.gov). It treats the *cause*.
Minoxidil is a vasodilator originally developed as a blood-pressure drug; its hair effect was discovered by accident. The exact mechanism isn't fully settled, but it is thought to shorten the resting (telogen) phase, prolong the growth (anagen) phase, and increase follicular blood flow. Crucially, minoxidil is a prodrug that must be activated by the enzyme sulfotransferase in the scalp — and people vary in how much of that enzyme they have, which is one reason minoxidil works dramatically for some and barely at all for others. Minoxidil treats the *follicle*, not the hormone.
Because one drug suppresses DHT and the other stimulates the follicle, combining them is the standard dermatology approach for men who want maximum results.
This is where Hims-style marketing ("clinically proven") earns scrutiny, so here are real figures from the medical literature.
Finasteride 1 mg (oral). In the pivotal two-year trials behind FDA approval (Kaufman et al., *J Am Acad Dermatol* 1998; PMID 9486029), hair counts in a defined vertex area rose by a net mean of about 9.2% at 48 weeks and 15.4% at 96 weeks versus placebo. By two years, 83% of finasteride-treated men had no further visible hair loss (versus continued loss on placebo), and global photographic review rated 48% of men improved at one year and 66% at two years, compared with about 7% on placebo (figures summarized in the FDA PROPECIA label and a DrugBank review). Long-term data are encouraging: in a five-year multinational study, finasteride users gained about 38 hairs from baseline in a defined area while placebo users *lost* 239 (PMID 11809594). Finasteride's strongest, most reliable effect is stopping loss — regrowth is a bonus, not a guarantee.
Minoxidil 5% (topical). Randomized trials consistently show increased hair counts with 5% topical minoxidil, though the magnitude varies because of the sulfotransferase differences noted above. In a randomized, double-blind study of a 5% formulation, men gained roughly 20–22 hairs/cm² from baseline by week 16 (PMID 29659116, a noninferiority trial comparing two 5% minoxidil products). Effects plateau and reverse within months of stopping.
The combination. A 2025 systematic review and meta-analysis of seven randomized controlled trials (N≈396) found that a topical minoxidil–finasteride combination beat minoxidil alone for hair density, hair diameter, and global photographic assessment, with the strongest signal for "marked improvement" (odds ratio 3.29) (PubMed 41127390; Frontiers in Medicine 2025). A separate 3-arm pilot RCT (Rossi et al., *J Cosmet Dermatol* 2024; DOI 10.1111/jocd.15953) evaluated a topical finasteride+minoxidil combination over six months, with assessments at three and six months. So the combo Hims sells has legitimate evidence behind it — though most of that evidence is for *topical* finasteride+minoxidil, which is itself not FDA-approved (see below).
Timeline. Whatever the product, expect nothing fast. Visible change typically takes 3–6 months, with fuller results around 9–12 months, and an early "shedding" phase (more shedding before regrowth) is common with both drugs (Hims; GoodRx). Benefits last only as long as you keep taking the medication.
This is the single most important thing Hims marketing tends to blur.
None of this means compounded or off-label options don't work — many do, and dermatologists prescribe them routinely. But "compounded" means the *specific product* hasn't been reviewed by the FDA for safety, efficacy, or manufacturing quality the way a brand-name drug has. If a product's approval status matters to you, oral finasteride 1 mg plus 5% topical minoxidil is the all-FDA-approved combination.
Finasteride. The best-known risks are sexual: decreased libido, erectile dysfunction, and reduced ejaculate volume. In trials these affected a low single-digit percentage of men and usually resolved on stopping (FDA PROPECIA label). The harder, more contested issue is persistent side effects. The FDA label itself now notes reports of sexual dysfunction that *continued after discontinuation*, plus reports of depression and suicidal ideation (FDA PROPECIA label, accessdata.fda.gov). A subset of users describe post-finasteride syndrome (PFS) — persistent sexual, neurological, and psychological symptoms after stopping. The medical community is genuinely divided on whether PFS is a distinct causal entity or a rare cluster of overlapping problems, and the evidence base is limited by reliance on spontaneous reporting (Irwig, *Andrology* 2022; PFS Foundation). Two takeaways: the *probability* of lasting harm appears low, but it is real enough to be on the FDA label, and you deserve to know about it before starting.
Critical contraindication: finasteride is dangerous in pregnancy. It can cause birth defects in a male fetus, so women who are or may become pregnant must not take it or handle broken/crushed tablets. Finasteride also lowers PSA, which can mask prostate-cancer screening results — tell any doctor ordering a PSA that you take it.
Minoxidil. Topical minoxidil's side effects are mostly local and minor: scalp itching, dryness, flaking, and irritation (often from the propylene-glycol vehicle), reported in a minority of users. Unwanted facial hair (hypertrichosis) can occur, usually from product migrating off the scalp. Serious cardiovascular effects are rare with topical use; oral minoxidil carries a higher cardiovascular risk profile and needs medical supervision. Early shedding is expected, not a reason to stop.
A good fit if you:
Look elsewhere or talk to a doctor first if you:
As of 2025, Hims hair pricing runs roughly $15 to $60+ per month depending on the product and plan length (Hims; pricing varies by promotion and subscription term):
Consultation and shipping are free. The honest value verdict: the medications are cheap as generics, so you're paying for convenience. Generic finasteride 1 mg can run only a few dollars a month with a discount card at a retail pharmacy, and generic 5% minoxidil is inexpensive on Amazon or at any drugstore. If you're price-sensitive and don't mind getting your own prescription filled, you can beat Hims' bundle prices. What Hims sells is the *frictionless system* — intake, prescription, refills, and delivery in one subscription — plus convenience extras (the shampoo and biotin gummies have little to no hair-regrowth evidence and shouldn't drive your decision).
Two cautions on cost: the multi-month plans bill up front, and subscriptions auto-renew, so cancellation friction is a real consideration. Confirm the per-month math over the full committed term, not the "starting at" headline.
Hims' edge is brand, polish, and an easy app. Its weaknesses versus a dermatologist are the thin asynchronous evaluation and reliance on compounded products for its flagship combination sprays.
The *drugs* Hims dispenses — finasteride and minoxidil — are the most evidence-backed hair-loss treatments available for men, and combining them is legitimately more effective than either alone. On that level, Hims Hair "works" because the underlying science works.
Hims itself is a convenience layer, and a competent one: free async consult, US-licensed providers, discreet auto-shipped refills. The trade-offs are that you'll usually pay a premium over generics, you may be steered toward compounded, non-FDA-approved topical formulations, and the multi-month, auto-renewing plans favor the company's economics. Before starting, take finasteride's small-but-real risk of persistent sexual and mood side effects seriously, understand that results take 3–6 months and vanish if you stop, and price out generics so you know exactly what the convenience is costing you. For a man who wants effective, hassle-free treatment and has weighed the risks, Hims is a reasonable choice — just go in knowing you're paying for the *delivery system*, not a better molecule.
*This article is for education and is not medical advice. Finasteride is a prescription drug with real risks; discuss it with a licensed clinician before starting, and stop and seek care if you experience mood changes or persistent side effects.*
Hims Hair targets male-pattern baldness two ways at once. Finasteride blocks the enzyme 5-alpha-reductase, which converts testosterone into DHT, the hormone that shrinks genetically susceptible scalp follicles; lowering scalp DHT slows that miniaturization. Minoxidil works on a different pathway, widening blood vessels and prolonging the follicle's active growth (anagen) phase to reactivate dormant follicles and thicken existing hairs. Used together as a daily scalp spray, they aim to slow loss (finasteride) while stimulating regrowth (minoxidil).
Active ingredient: Finasteride 1mg + Minoxidil 5%
The active ingredients are individually well-validated. In the pivotal oral finasteride 1mg trials cited on the Propecia FDA label, 48% of men had increased hair count at 12 months versus 7% on placebo; in 5-year data, 48% showed increased growth, 42% had no further loss, and about 10% continued losing. For topical minoxidil, a 393-man, 48-week randomized trial found 5% minoxidil produced roughly 45% more regrowth than 2% minoxidil by target-area hair counts. Combining a 5-alpha-reductase inhibitor with minoxidil generally outperforms either alone. Important caveat: Hims' specific compounded 0.3% topical finasteride / 6% minoxidil spray has not been studied in large dedicated FDA trials, so its exact regrowth numbers are inferred from the individual drugs, not proven for this product.
A realistic timeline of what Hims Hair (Finasteride + Minoxidil) users typically experience. Individual results vary; this is educational, not medical advice.
You complete an online intake and photos through Hims; a licensed provider reviews your history and, if appropriate, prescribes the finasteride + minoxidil regimen, which ships discreetly to your door. You start daily use; no visible change yet.
Many users experience temporary increased shedding, most often from minoxidil (the so-called "dread shed"), typically beginning 2-4 weeks in and easing by around month 3-4. This is a normal sign follicles are cycling, not a sign of failure. Consistency matters most here.
Shedding usually settles and some people first notice reduced fall-out and early fine "baby hairs." In trials a large share of finasteride users showed measurable improvement by around month 4, though changes are often subtle and easy to miss day to day.
This is when most noticeable thickening and regrowth appears with consistent daily use; combination therapy studies report high rates of improvement at one year. Results vary widely by person, age, and how advanced the loss is, and combining the two does not speed up the natural hair-growth cycle.
Benefits require continued daily use; long-term studies (2-5 years) show sustained results overall, though gains can plateau and may gradually taper over years. If you stop, regained hair is typically lost within several months. Discuss any side effects (including sexual side effects with finasteride) with your provider.
Local effects are most common: scalp itching, dryness, flaking, redness, or irritation from the alcohol/minoxidil base, plus possible unwanted facial hair if the product migrates. Minoxidil can cause a temporary early shed in the first weeks. Finasteride's known risks include decreased libido, erectile dysfunction, and ejaculation disorders (roughly 1-2% in oral trials, modestly above placebo). Serious or rarer concerns on the FDA finasteride label include depression, suicidal ideation, gynecomastia, and sexual side effects that can persist after stopping (sometimes called post-finasteride syndrome). Critically, in April 2025 the FDA alerted clinicians and consumers about compounded topical finasteride after reports of erectile dysfunction, anxiety, suicidal ideation, brain fog, depression, fatigue, insomnia, decreased libido, and testicular pain, many of which continued after discontinuation; topical use lowers but does not eliminate systemic absorption. Minoxidil can rarely cause dizziness or rapid heartbeat. Stop and seek care for chest pain, swelling, fainting, or mood changes.
Starts at $37/mo from Hims.
As of 2026, the Hims topical finasteride + minoxidil spray starts around $35/month, with the lowest per-month price when billed and shipped on a longer (for example, multi-month) cycle. For comparison, Hims oral finasteride runs about $22/month and standalone minoxidil about $15/month. There may also be a low-cost or one-time medical consultation fee. These are cash-pay telehealth/compounded products, so insurance typically does not cover them; generic oral finasteride filled at a pharmacy with a prescription can sometimes be cheaper (often around $10-25/month with discount cards) for those who do not need the topical convenience.
Prices current as of May 29, 2026 and exclude promo codes; cash-pay and channel pricing change frequently — confirm with the pharmacy or provider.
If you want a low-effort, single-step routine and you understand that the spray is a compounded (not FDA-approved) product, Hims Hair is a reasonable, affordable option built on two proven actives. Discuss the 2025 FDA topical-finasteride safety alert with the prescribing clinician before starting, and know that finasteride is for men only and must never be handled by anyone who is or may become pregnant. Results typically take 3-6 months and reverse if you stop. This is general information, not medical advice.
For most men, yes, based on the individual ingredients. Oral finasteride increased hair count in about 48% of men at one year versus 7% on placebo, and 5% topical minoxidil meaningfully boosts regrowth; combining the two generally outperforms either alone. That said, Hims' specific compounded spray has not been tested in large dedicated trials, so its exact results are inferred. Visible changes typically take 3-6 months and require continued use.
No. The individual drugs are FDA-approved in other forms, but Hims' compounded topical finasteride/minoxidil spray is not approved as a finished product. There is currently no FDA-approved topical finasteride, and in April 2025 the FDA issued a safety alert about compounded topical finasteride products.
The topical finasteride + minoxidil spray starts around $35/month as of 2026, and is usually cheapest on longer billing cycles. For comparison, Hims oral finasteride is about $22/month and minoxidil about $15/month. It is cash-pay and generally not covered by insurance.
Common effects include scalp itching, dryness, flaking, and temporary early shedding. Finasteride can cause decreased libido, erectile dysfunction, and rarely depression, mood changes, or sexual side effects that persist after stopping. In April 2025 the FDA warned that compounded topical finasteride has been linked to erectile dysfunction, anxiety, depression, brain fog, insomnia, and testicular pain, some lasting after discontinuation. Seek care for chest pain, swelling, fainting, or mood changes.
Expect about 3-6 months of daily use before visible changes, with peak results around 12 months. Many men see a temporary shed in the first few weeks before regrowth, which is normal.
Yes. Because it contains finasteride, you must complete a telehealth evaluation with a licensed clinician who reviews your history before it can be prescribed and shipped.
The benefits reverse. Within a few months of stopping, DHT suppression and follicle stimulation end, and you typically lose the regrowth and resume your genetic hair loss. It is an ongoing treatment, not a cure.
No. Finasteride is not approved for women and must never be handled by anyone who is or may become pregnant, because it can cause birth defects in a male fetus. Women with hair loss should ask a clinician about female-specific options such as topical minoxidil.
It may lower systemic exposure, but it does not eliminate it. The FDA's April 2025 alert reported that compounded topical finasteride can still cause sexual, mood, and cognitive side effects, sometimes persisting after stopping, so discuss the risks with the prescribing clinician.
Affiliate link — we may earn a commission at no extra cost to you, and it never changes our rankings or score. Disclosure
Legitimate ways to lower your cost. We don’t sell Hims Hair (Finasteride + Minoxidil) — this is independent guidance, not medical or financial advice. Confirm current terms with the program and your clinician.
Many brand-name drugs have a manufacturer copay-savings program on the drug’s official site. Check the maker’s website for a current savings card (commercial insurance usually required; government insurance excluded).
If you’re uninsured or low-income, free or reduced-cost medication may be available through patient assistance programs. Search MedicineAssistanceTool (PhRMA) and NeedyMeds.
Filling a 90-day supply instead of monthly often lowers the per-month cost and cuts pharmacy trips. Ask your prescriber and pharmacy whether it’s an option for you.
Same-category options, scored on the same six-axis rubric. Higher is better.
| H | Hims Hair (Finasteride + Minoxidil)this reviewPrescription | 8.3/10 | — |
| H | Happy Head Prescription TopicalOver-the-counter | 8.2/10 | Read → |
| K | KeepsPrescription | 8.0/10 | Read → |
| M | Musely Hair Formula RxOver-the-counter | 8.0/10 | Read → |
| V | Vegamour GRO Hair SerumOver-the-counter | 7.8/10 | Read → |
| N | Nutrafol MenOver-the-counter | 7.0/10 | Read → |